Deferred Tax Assets, Valuation Allowance of ORAMED PHARMACEUTICALS INC. from 31 Aug 2011 to 31 Dec 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary: ORAMED PHARMACEUTICALS INC. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Aug 2011 to 31 Dec 2024.
ORAMED PHARMACEUTICALS INC. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $36,120,000, a 27% increase year-over-year.
Source SEC data: View on sec.gov

Deferred Tax Assets, Valuation Allowance, Quarterly (USD)

Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

ORAMED PHARMACEUTICALS INC. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2024	$36,120,000	+$7,647,000	+27%	31 Dec 2024	10-K	27 Mar 2025	2024	FY
Q4 2023	$28,473,000	-$4,332,000	-13%	31 Dec 2023	10-K	27 Mar 2025	2024	FY
Q4 2022	$32,805,000	+$6,146,000	+23%	31 Dec 2022	10-K	06 Mar 2024	2023	FY
Q4 2021	$26,659,000			31 Dec 2021	10-K	06 Mar 2023	2022	FY
Q3 2021	$25,073,000	+$5,681,000	+29%	31 Aug 2021	10-K	24 Nov 2021	2021	FY
Q3 2020	$19,392,000	+$3,154,000	+19%	31 Aug 2020	10-K	24 Nov 2021	2021	FY
Q3 2019	$16,238,000	+$3,356,000	+26%	31 Aug 2019	10-K	24 Nov 2020	2020	FY
Q3 2018	$12,882,000	+$1,583,000	+14%	31 Aug 2018	10-K	27 Nov 2019	2019	FY
Q3 2017	$11,299,000	+$2,080,000	+23%	31 Aug 2017	10-K	27 Nov 2019	2019	FY
Q3 2016	$9,219,000	+$2,563,000	+39%	31 Aug 2016	10-K	28 Nov 2018	2018	FY
Q3 2015	$6,656,000	+$1,078,000	+19%	31 Aug 2015	10-K	29 Nov 2017	2017	FY
Q3 2014	$5,578,000	+$1,246,000	+29%	31 Aug 2014	10-K	25 Nov 2016	2016	FY
Q3 2013	$4,332,000	+$1,124,000	+35%	31 Aug 2013	10-K	25 Nov 2015	2015	FY
Q3 2012	$3,208,000	+$1,395,000	+77%	31 Aug 2012	10-K	14 Nov 2014	2014	FY
Q3 2011	$1,813,000			31 Aug 2011	10-K	14 Nov 2014	2014	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.